Marquette Asset Management, LLC Edwards Lifesciences Corp Transaction History

Marquette Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	SELL	$69.28 - $93.38 $2,701 - $3,641	-39 Reduced 18.57%	171 $11,000
Q2 2023 Jul 28, 2023	BUY	$81.41 - $94.33 $17,096 - $19,809	210 New	210 $19,000
Q2 2022 Jul 15, 2022	SELL	$86.5 - $128.27 $234,674 - $347,996	-2,713 Reduced 99.82%	5 $0
Q1 2022 Apr 26, 2022	BUY	$101.96 - $128.34 $611 - $770	6 Added 0.22%	2,718 $320,000
Q2 2020 Jul 21, 2020	BUY	$57.54 - $76.95 $104,032 - $139,125	1,808 Added 200.0%	2,712 $187,000
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $43,292 - $57,901	904 New	904 $173,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Marquette Asset Management, LLC with notifications on news.